Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells
Sareh Bagheri-Josheghani, Mahmood Saffari, Hamed Mirzaei, Zahra Sadat Fateminasab, Mozhgan Derakhshan-Sefidi, Somaye Rashki, Bita Bakhshi · 2026
Read Nonantibiotic Treatment of Clinical Multidrug‐Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells by Sareh Bagheri-Josheghani, Mahmood Saffari, Hamed Mirzaei, Zahra Sadat Fateminasab, Mozhgan Derakhshan-Sefidi, Somaye Rashki, Bita Bakhshi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216856.txt.
Description
Sareh Bagheri-Josheghani and co-authors present a 2026 study testing a drug-free weapon against multidrug-resistant bacteria: the fluid that mesenchymal stem cells grow in, loaded into chitosan nanoparticles. The stem cell fluid carries natural antimicrobial factors, and the particles are meant to deliver them slowly.
The composite particles were about 85 nanometres wide with a positive surface charge, and they trapped 71 percent of the loaded material. Against resistant patient isolates, the combination killed far better than either the stem cell fluid or the nanoparticles alone, with an effect that grew with dose, which the authors describe as synergy. They present the construct as a promising route for infections that no longer answer to standard antibiotics.
Catalog record
| CREATOR | Sareh Bagheri-Josheghani, Mahmood Saffari, Hamed Mirzaei, Zahra Sadat Fateminasab, Mozhgan Derakhshan-Sefidi, Somaye Rashki, Bita Bakhshi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |